Zevra Therapeutics

ISIN US4884452065

 | 

WKN A2QLX7

Market cap (in EUR)
500 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 500 m
EPS, EUR 1.03
P/B ratio 2.3
P/E ratio 7.7
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 94 m
Net income, EUR 69 m
Profit margin 72.87%

What ETF is Zevra Therapeutics in?

There are 16 ETFs which contain Zevra Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Zevra Therapeutics is the L&G Pharma Breakthrough UCITS ETF.
ETF Weight Investment focus Fund size (in m EUR)
iShares Russell 2000 Swap UCITS ETF USD (Acc) 0.02%
Equity
United States
Small Cap
69
L&G Russell 2000 US Small Cap Quality UCITS ETF 0.03%
Equity
United States
Small Cap
214
Xtrackers Russell 2000 UCITS ETF 1C 0.02%
Equity
United States
Small Cap
2,184
Amundi Russell 2000 UCITS ETF EUR (C) 0.02%
Equity
United States
Small Cap
636
Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Acc 0.02%
Equity
United States
Small Cap
13
Invesco Nasdaq Biotech UCITS ETF 0.04%
Equity
United States
Health Care
Biotech
594
iShares Russell 2000 Swap UCITS ETF EUR Hedged (Acc) 0.02%
Equity
United States
Small Cap
120
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.04%
Equity
United States
Health Care
Biotech
69
Invesco Russell 2000 UCITS ETF Acc 0.02%
Equity
United States
Small Cap
289
iShares Nasdaq US Biotechnology UCITS ETF 0.04%
Equity
United States
Health Care
Biotech
1,218
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF EUR Hedged (Acc) 0.02%
Equity
United States
Small Cap
146
Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Dist 0.02%
Equity
United States
Small Cap
3
State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF USD 0.02%
Equity
United States
Small Cap
4,204
WisdomTree Russell 2000 0.02%
Equity
United States
Small Cap
7
L&G Pharma Breakthrough UCITS ETF 2.97%
Equity
World
Health Care
Innovation
22
Amundi Russell 2000 UCITS ETF USD 0.02%
Equity
United States
Small Cap
233
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.